Skip to main content
. 2016 Nov 25;107(12):1785–1790. doi: 10.1111/cas.13076

Figure 2.

Figure 2

Waterfall chart for maximum reduction in the sum of the products of diameters of measurable lesions (SPD) in Japanese patients with relapsed or refractory mantle cell lymphoma treated with ibrutinib, as determined by the study's Independent Review Committee (response‐evaluable population, n = 16).